HRES 1285
119th Congress
House
Health
Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.
Introduced: May 14, 2026
See on congress.gov
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 14, 2026
Referred to the House Committee on Energy and Commerce.
May 14, 2026
Submitted in House
What's happening now
Referred to the House Committee on Energy and Commerce.
Committees of jurisdiction
1